
Monday, August 09, 2021 3:28:33 PM
Okay, I will answer my own question:
Thursday, August 12, 2021
And the stunning truth of the matter is that this generation, save the military, doesn’t value freedom. Instead, it values comfort. It values convenience and coddling, and conformity.
Recent TIL News
- Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago • GlobeNewswire Inc. • 05/23/2025 11:00:00 AM
- Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated • GlobeNewswire Inc. • 05/22/2025 10:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:06:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:05:44 AM
- Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2025 11:00:28 AM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/02/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2025 09:00:15 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/14/2025 08:32:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/14/2025 08:30:40 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/14/2025 08:30:08 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/31/2025 10:33:14 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/04/2025 12:44:30 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2025 12:42:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2025 12:14:03 PM
- Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/04/2025 12:09:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2025 12:05:26 PM
- Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody • GlobeNewswire Inc. • 01/14/2025 12:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 10:00:31 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2024 10:02:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 12:39:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 12:01:02 PM
- Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/26/2024 01:42:03 AM
Authentic Events, LLC To Broadcast its First Pay Per View with Lingerie Fighting Championships on July 4th 2025 • AHRO • May 22, 2025 8:30 AM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM